InvestorsHub Logo
Followers 31
Posts 2650
Boards Moderated 0
Alias Born 10/28/2013

Re: Steppenwolf_Speaks post# 45345

Thursday, 11/19/2015 3:30:08 PM

Thursday, November 19, 2015 3:30:08 PM

Post# of 719868
It is a certainty that Cramer and Feuerstein want NWBO dead. Whether anyone in big pharma thinks like that... I would think so, but I respect your statement that such is not inline with your experience.

However, Feuerstein and Cramer, and the new arshlo on the block, Martin Shkreli, represent the interests of associated hedge funds. Those hedge funds have big pharma holdings that would be threatened by any major change to the Oncology sector. If Northwest is successful, there will be a very large upheavel in the oncology sector. Period. I thought I heard Feuerstein recently quoted as saying as much, but cannot find that quote.

I'm trying to think of examples where Cramer or Feuerstein were clearly attacking NWBO to protect a holding... and the only one that immediately comes to mind is Celldex. And Celldex is not truely big pharma, it is medium pharma. So... I will keep my ears open for further examples...

But Feuerstein is coached by an MD with direct ties to big pharma. I don't remember the details, but I will track those down if you are interested.

The SEC presumably tolerates Feuerstein and the like because there is a need for balance in this sector due to excessive pumping of stocks at the expense of retail. But I don't believe that is really a major consideration. Look at the AEZS death spiral magic B warrants deal that went down a few months ago. That totally crooked deal handed 90% of retail's shares to the institutions using a convoluted contract intended to delay retails realization of the true nature. In fact it was many weeks before the broader retail realized what had happened. By that time it was too late. And there was not one word from the great protectors of retail, Feuerstein and Cramer. No, they are crooks, just as Cramer confessed. They are working in the interest of associated hedge funds, and in that work, they attack any threat to their big pharma holdings. So... it may not be big pharma per-se... maybe that is where we may not dissagree here.

And those crooks dominate the retail small biocap space. Why should two men. An admitted securities criminal and his flunkie, be allowed to dominate something as valuable as the small-cap biotech space. Like the rain forests, a major source of new drugs... yet people rally to protect the rain forests, but there is no rally to protect small-cap biotech.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News